Suppr超能文献

利尿治疗后发生的肺水肿:一例报告。

Pulmonary edema following diuretic therapy: A case report.

作者信息

Liu Lixia, Zhang Qian, Zhang Tao, Wu Xinhui, Sun Lixiao, Li Bin, Wang Xiaoting, Chao Yangong, Hu Zhenjie

机构信息

Department of Intensive Care Unit (ICU), The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei.

Department of Intensive Care Unit (ICU), Peking Union Medical College Hospital.

出版信息

Medicine (Baltimore). 2020 Feb;99(8):e19180. doi: 10.1097/MD.0000000000019180.

Abstract

INTRODUCTION

Diuretics are a commonly used for the treatment of acute pulmonary edema. However, inappropriate administration of diuretic drugs can result in clinical treatment failure and cause acute pulmonary edema. This is due to rapid decreases in intravascular volume as a result of diuretic treatment. To date, the clinical phenomenon of inappropriate use of diuretics leading to acute pulmonary edema remains unexplored and unrecognized. Here, we report the first case of this problem-pulmonary edema following diuretic therapy.

PATIENT CONCERNS

A 71-year-old male patient who was intubated and transferred to the intensive care unit (ICU) due to respiratory failure was initially diagnosed with pneumonia as a complication of acute respiratory distress syndrome (ARDS). After treatments including antibiotics, lung protective ventilation strategies, and restrictive fluid management, his respiratory symptoms improved. However, the patient's dyspnea became more severe after experimental diuretic therapy.

DIAGNOSIS

A point-of-care ultrasound (POCUS) examination showed increased extravascular lung water retention during a hypovolemic state. After full examinations and analysis, the diagnosis of acute pulmonary edema was determined.

INTERVENTIONS

The most likely cause of acute pulmonary edema was left ventricular (LV) hyperdynamic status due to a hypovolemic status caused by excessive diuretic therapy. Consequently, we administrated intravenous fluids and a β-receptor blocker to the patient.

OUTCOMES

Following these treatment, the patient's respiratory distress improved remarkably.

CONCLUSION

We report the first case of pulmonary edema following diuretic therapy to stress the need of physicians to follow guidelines of clinical practice. Maintaining an appropriate volume status and treatment of β-receptor blockers is the key to reversing the progress of this adverse effect. In this process, POCUS is a reliable diagnostic tool to identify the cause of acute pulmonary edema and can increase the accuracy of clinical evaluations. It is likely that a wider use of POCUS will help physicians to obtain a faster, and more accurate, diagnosis of the etiology of acute pulmonary edema, thus allowing a more appropriate therapy.

摘要

引言

利尿剂是治疗急性肺水肿的常用药物。然而,利尿剂使用不当可导致临床治疗失败并引发急性肺水肿。这是由于利尿剂治疗导致血管内容量迅速减少所致。迄今为止,利尿剂使用不当导致急性肺水肿的临床现象仍未得到充分研究和认识。在此,我们报告首例此类问题——利尿剂治疗后肺水肿。

患者情况

一名71岁男性患者因呼吸衰竭插管并转入重症监护病房(ICU),最初被诊断为急性呼吸窘迫综合征(ARDS)并发症肺炎。经过抗生素、肺保护性通气策略和限制性液体管理等治疗后,其呼吸症状有所改善。然而,在进行试验性利尿剂治疗后,患者的呼吸困难变得更加严重。

诊断

床旁超声(POCUS)检查显示在低血容量状态下血管外肺水潴留增加。经过全面检查和分析,确定诊断为急性肺水肿。

干预措施

急性肺水肿最可能的原因是过度利尿剂治疗导致的低血容量状态引起的左心室(LV)高动力状态。因此,我们给患者静脉输注液体并使用了β受体阻滞剂。

结果

经过这些治疗,患者的呼吸窘迫明显改善。

结论

我们报告首例利尿剂治疗后肺水肿病例,以强调医生遵循临床实践指南的必要性。维持适当的容量状态和使用β受体阻滞剂治疗是扭转这种不良反应进展的关键。在此过程中,POCUS是识别急性肺水肿病因的可靠诊断工具,可提高临床评估的准确性。广泛使用POCUS可能有助于医生更快、更准确地诊断急性肺水肿的病因,从而进行更恰当的治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/666f/7034745/69ae7af91ff1/medi-99-e19180-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验